Mosapride citrate salt dihydrate is primarily used as a prokinetic agent to enhance gastrointestinal motility. It is commonly prescribed for the treatment of functional gastrointestinal disorders such as chronic gastritis, gastroesophageal reflux disease (GERD), and dyspepsia. By stimulating serotonin 5-HT4 receptors in the enteric nervous system, it accelerates gastric emptying and improves intestinal transit, alleviating symptoms like bloating, nausea, and abdominal discomfort. Additionally, it is utilized in postoperative care to prevent ileus and promote recovery of normal bowel function. Its minimal impact on dopamine receptors reduces the risk of extrapyramidal side effects, making it a safer option for long-term use in patients with motility-related gastrointestinal issues.